Track-2 (Emerald 3): Chemical Biology Approaches to Drug Discovery

Confirmed Speakers to date

Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences
Amit Banerjee, Professor, Wayne State University
Petr Bartunek, Group Leader, Institute of Molecular Genetics
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners
Maria Costi, Professor, University of Modena and Reggio Emilia
Mariam Degani, Professor, Institute of Chemical Technology
Umesh Desai, Professor, Virginia Commonwealth University
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd.
Roland Durner, Global Head of LSB Distributors, Tecan Trading AG
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc
Ajith Kamath, Head, Pfizer Inc
Stefan Krauss, Director, University Of Oslo
Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases
Sergei Makarov, Chief Executive Officer, Attagene Inc
Harish Pant, Senior Investigator, National Institute of Health
Raphael Rahmani, Research Fellow, Monash University
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery
Lesley Schultz, Product Manager, Agilent Technologies
Anamik Shah, Vice Chancellor, Gujarat Vidyapith
John Watson, Director of Marketing, Promega Corporation